ORPHA:2903
Familial spontaneous pneumothorax
Publications
97
46.9th percentile
Trials
0
Interventional, condition-specific
Researchers
429
Distinct authors in sample
Gene link
FLCN
Strong
Readiness
3/6
Stages with a signal
Clinical definition (Orphanet)
Familial spontaneous pneumothorax is a rare, genetic pulmonary disease characterized by the uni- or bilateral accumulation of air in the pleural cavity in persons with a positive family history and no underlying lung disease or previous chest trauma. Patients typically present dyspnea associated with acute onset of sharp and steady pleutiric chest pain of variable severity (which resolves within 24h even though pneumothorax is still present). Reflex tachycardia and/or respiratory or circulatory compromise may be observed. Other syndromes (e.g. Birt-Hogg-Dube, Marfan or Ehlers-Danlos syndromes) may be associated.
How rare: 1-5 / 10 000 — about one to five people per ten thousand (still uncommon, but less ultra-rare).
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0008259
- MeSH:C566795
- OMIM:173600
- UMLS:C1868193
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
3/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Strong — FLCN
- LiteraturePresent
97 matched papers (35 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialPartial
None under the specific name; 119 for broader category pneumothorax
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (FLCN).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
97
97 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
97 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
35 in the last 10 years · high confidence · 46.9th percentile (publications denominator)
Phrase hits: 97 · MeSH hits: 0
Who's working on it?
429
Distinct author names in 97 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Maher ER6 papers · 2026
Department of Medical Genetics, University of Cambridge and NIHR Cambridge Biomedical Research Centre and Cancer Research UK Cambridge Cancer Centre, Cambridge, CB2 0QQ, UK. erm1000@medschl.cam.ac.uk.
Papers in Europe PMC - 02Marciniak SJ6 papers · 2026
Cambridge Institute for Medical Research, Cambridge Biomedical Campus, University of Cambridge, Cambridge, UK.
Papers in Europe PMC - 03Henske EP5 papers · 2022
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts Harvard Medical School, Boston, Massachusetts.
Papers in Europe PMC - 04Babar J3 papers · 2026
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Papers in Europe PMC - 05Garcia CK3 papers · 2012Papers in Europe PMC
- 06Holden S3 papers · 2026
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Papers in Europe PMC - 07Karia S3 papers · 2026
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Papers in Europe PMC - 08Kurihara M3 papers · 2022
Pneumothorax Research Center and Division of Thoracic Surgery, Nissan Tamagawa Hospital, Setagayaku, Tokyo, Japan.
Papers in Europe PMC - 09Linehan WM3 papers · 2022
Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, CRC Room 15940, Bethesda, MD 20892-1107, USA.
Papers in Europe PMC - 10Liu Y3 papers · 2022
Department of Thoracic Surgery, Peking University People's Hospital, Beijing 100044, China.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name. 2 observational studies did — shown below because natural-history and cohort work can be an important step toward a trial. 119 trials are registered for pneumothorax, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
119 interventional trials matched pneumothorax, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: pneumothorax
119
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT06686251·RECRUITING·Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial
Conditions: Consolidation · Lung Injury · Pleural Effusion · Pneumothorax·Matched via name phrase
- NCT06883188·NOT YET RECRUITING·Stop Air Leak by Talc or Autologous Blood Patch Therapy
Conditions: Pneumothorax Spontaneous Secondary·Matched via name phrase
- NCT06842043·NOT YET RECRUITING·AI-Assisted Chest X-Ray for Misplaced Endotracheal and Nasogastric Tubes and Pneumothorax in Emergency and Critical Care Settings
Conditions: Endotracheal Tube · Nasogastric Tube · Pneumothorax·Matched via name phrase
- NCT06411431·RECRUITING·Early Chest Tube Removal After Surgery for Primary Spontaneous Pneumothorax: A Randomized Controlled Trial
Conditions: Primary Spontaneous Pneumothorax·Matched via name phrase
- NCT07319572·NOT YET RECRUITING·Comparison of Chest Tube Wound Closure: Comparison Between Purse String Method and Plug Method.
Conditions: Pneumothorax · Hemothorax · Chest Tube · Chest Tube Removal·Matched via name phrase
- NCT06471608·NOT YET RECRUITING·Impact of Ambulatory Management for Primary Spontaneous Pneumothorax in the Emergency Department on Quality of Life
Conditions: Primary Spontaneous Pneumothorax · Quality of Life · Ambulatory Care · Chest Tube·Matched via name phrase
- NCT06053476·RECRUITING·Optimal Postoperative Chest Tube and Pain Management in Patients Surgically Treated for Primary Spontaneous Pneumothorax (Pneumotrial)
Conditions: Pneumothorax, Primary Spontaneous · VATS · Pain, Postoperative · Locoregional Anaesthesia·Matched via name phrase
- NCT07186933·RECRUITING·Driving Pressure During Surgeries With High Risk for Postoperative Pulmonary Complications
Conditions: Postoperative Pulmonary Atelectasis · Postoperative Pulmonary Complications · Postoperative Respiratory Failure · Postoperative Bronchospasm·Matched via name phrase
- NCT07625176·ENROLLING BY INVITATION·Evaluating the Use of an App in Pleural Disease: Algorithm-supported Clinical Decision Making Versus Usual Care
Conditions: Pleural Diseases · Pneumothorax Spontaneous Primary · Pneumothorax Spontaneous Secondary · Pleural Effusion·Matched via name phrase
- NCT07331805·NOT YET RECRUITING·Conservative Management in Primary Spontaneous Pneumothorax: a Multicenter Randomized Non-inferiority Study
Conditions: Primary Spontaneous Pneumothorax (PSP) · Conservative Management (Active Observation)·Matched via name phrase
- NCT07211529·RECRUITING·Intraoperative Paravertebral Block and Postoperative Complications
Conditions: Video-assisted Thoracoscopic Surgery (VATS) · Lung Cancer (Diagnosis) · Pulmonary Infections · Respiratory Failure Without Hypercapnia·Matched via name phrase
- NCT07167992·NOT YET RECRUITING·Comparison of Talc Slurry Versus Talc Insufflation: A Study on Effectiveness, Safety, and Hospital Outcomes in Pleurodesis
Conditions: Pneumothorax Spontaneous Primary · Pneumothorax Spontaneous Secondary · Pleural Effusion, Malignant · Pleurodesis·Matched via name phrase
- NCT03691480·RECRUITING·Outpatient Management of Primary Spontaneous Pneumothorax: Pigtail Catheter With Unidirectional Valve vs. Exsufflation, Randomized Prospective Study
Conditions: Pneumothorax, Spontaneous·Matched via name phrase
- NCT06958848·RECRUITING·16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy
Conditions: Pneumothorax · Pleural Effusion·Matched via name phrase
- NCT06731647·RECRUITING·Non-steroidal Anti-inflammatory Drugs in Pleurodesis
Conditions: Non-steroidal Anti-inflammatory Drugs · Pleurodesis · Pneumothorax · Pain Management·Matched via name phrase
Observational and natural-history studies
2 observational studies match this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.
Recruiting or not-yet-recruiting
- NCT00033137·RECRUITING·Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
Conditions: Kidney Neoplasms · Kidney Cancer · Pneumothorax · FLCN Protein, Human·Matched via name phrase
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Familial spontaneous pneumothorax"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Familial spontaneous pneumothorax" OR "FLCN"
Recall-expansion terms: FLCN
Study-type breakdown: 0 interventional · 2 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"pneumothorax"
Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-26T21:37:38.641Z
